One study showed that the maturation of DCs can induce the production on CD4 +, CD8 + T cells and activated NKs, making it to become candidate target for immunotherapy of cervical cancer (Dhandapani et al., 2021). This evidence concerns the gene CD8A and cervical carcinoma.